|
Patient-matched tissue and liquid biopsies identify shared and acquired genomic alterations in breast cancer. |
| |
|
Employment - Foundation Medicine |
Stock and Other Ownership Interests - Roche |
| |
|
Employment - Foundation Medicine |
Stock and Other Ownership Interests - Roche/Genentech |
| |
|
Employment - Foundation Medicine |
Stock and Other Ownership Interests - Roche/Genentech |
| |
|
Employment - Foundation Medicine |
| |
|
No Relationships to Disclose |
| |
|
Stock and Other Ownership Interests - Roche |
| |
|
Employment - Foundation Medicine |
Stock and Other Ownership Interests - Roche/Genentech |
Travel, Accommodations, Expenses - Foundation Medicine; Roche/Genentech |
| |
|
Employment - Foundation Medicine |
Leadership - Foundation Medicine |
Stock and Other Ownership Interests - Foundation Medicine |
Consulting or Advisory Role - Celsius Therapeutics |
Research Funding - Foundation Medicine |
| |
|
Employment - Foundation Medicine |
Stock and Other Ownership Interests - Roche |
| |
|
No Relationships to Disclose |
| |
|
Employment - Foundation Medicine; Roche/Genentech |
Leadership - Foundation Medicine; Roche/Genentech |
Stock and Other Ownership Interests - Roche/Genentech |
Travel, Accommodations, Expenses - Foundation Medicine; Roche/Genentech |
| |
|
Employment - Roche/Genentech |
Stock and Other Ownership Interests - Roche/Genentech |
| |
|
Stock and Other Ownership Interests - Ocean Genomics (I) |
Research Funding - AstraZeneca; Blueprint Medicines; GE Healthcare; H3 Biomedicine; Illumina |
| |
|
No Relationships to Disclose |